THE KARYOTYPE OF PHILADELPHIA CHROMOSOME-NEGATIVE, BCR REARRANGEMENT-POSITIVE CHRONIC MYELOID-LEUKEMIA

被引：16
|
作者：
WEINSTEIN, ME
GROSSMAN, A
PERLE, MA
WILMOT, PL
VERMA, RS
SILVER, RT
ARLIN, Z
ALLEN, SL
AMOROSI, E
WAINTRAUB, SE
SHAPIRO, LR
BENN, PA
机构：
[1] WESTCHESTER CTY MED CTR,VALHALLA,NY 10595
[2] NEW YORK MED COLL,VALHALLA,NY 10595
[3] NYU MED CTR,NEW YORK,NY 10016
[4] SUNY HLTH SCI CTR,LONG ISLAND COLL HOSP,BROOKLYN,NY
[5] CORNELL UNIV,MED CTR,NEW YORK HOSP,NEW YORK,NY 10021
[6] HOLY NAME HOSP,TEANECK,NJ
[7] CORNELL UNIV,N SHORE UNIV HOSP,COLL MED,MANHASSET,NY 11030
来源：
CANCER GENETICS AND CYTOGENETICS | 1988年 / 35卷 / 02期
关键词：
D O I：
10.1016/0165-4608(88)90244-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：223 / 229
页数：7
相关论文
共 50 条
  • [31] PHILADELPHIA CHROMOSOME-NEGATIVE CHRONIC MYELOGENOUS LEUKEMIA AND CHRONIC MYELOMONOCYTIC LEUKEMIA
    KANTARJIAN, HM
    KURZROCK, R
    TALPAZ, M
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1990, 4 (02) : 389 - 404
  • [32] Translocation of BCR to chromosome 9 in a Philadelphia-negative chronic myeloid leukemia
    Brunel, V
    Sainty, D
    Costello, R
    Mozziconacci, MJ
    Simonetti, A
    Arnoulet, C
    Coignet, L
    Bouabdallah, R
    Gastaut, JA
    Gabert, J
    LafagePochitaloff, M
    CANCER GENETICS AND CYTOGENETICS, 1995, 85 (01) : 82 - 84
  • [33] Analysis of Philadelphia chromosome-negative BCR-ABL-positive chronic myelogenous leukemia by hypermetaphase fluorescence in situ hybridization
    Seong, D
    Kantarjian, HM
    Albitar, M
    Arlinghaus, R
    Xu, J
    Talpaz, M
    Rios, MB
    Guo, JQ
    O'Brien, S
    Siciliano, M
    ANNALS OF ONCOLOGY, 1999, 10 (08) : 955 - 959
  • [34] LACK OF BCR REARRANGEMENT IN JUVENILE CHRONIC MYELOID-LEUKEMIA
    TOREN, A
    MANDEL, M
    AMARIGLIO, N
    HAKIM, Y
    BROKSIMONI, F
    RECHAVI, G
    NEUMANN, Y
    RAMOT, B
    MEDICAL AND PEDIATRIC ONCOLOGY, 1991, 19 (06): : 493 - 495
  • [35] Progression of Philadelphia positive chronic myeloid leukemia to Philadelphia negative and bcr-abl positive disease
    Zivanovic, Biljana Todoric
    Strnad, Milica
    Stamatovic, Dragana
    Elez, Marija
    CHROMOSOME RESEARCH, 2013, 21 : S105 - S106
  • [36] QUANTIFICATION OF THE BREAKPOINT CLUSTER REGION REARRANGEMENT FOR CLINICAL MONITORING IN PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOID-LEUKEMIA
    VERSCHRAEGEN, CF
    TALPAZ, M
    HIRSCHGINSBERG, CF
    PHERWANI, R
    RIOS, MB
    STASS, SA
    KANTARJIAN, HM
    BLOOD, 1995, 85 (10) : 2705 - 2710
  • [37] PYODERMA GANGRAENOSUM ASSOCIATED WITH PHILADELPHIA-CHROMOSOME-NEGATIVE CHRONIC MYELOID-LEUKEMIA
    KOVARY, PM
    LONAUER, G
    NIEDORF, H
    NAUTSCH, C
    PAWLOWITZKI, IH
    DERMATOLOGICA, 1977, 154 (06): : 360 - 366
  • [38] Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome positive chronic myeloid leukemia in chronic phase
    Jootar, S.
    BLOOD REVIEWS, 2007, 21 : S121 - S121
  • [39] M-BCR BREAKPOINT LOCATION DOES NOT PREDICT SURVIVAL IN PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOID-LEUKEMIA
    ZACCARIA, A
    MARTINELLI, G
    BUZZI, M
    ZUFFA, E
    ZAMAGNI, MD
    TESTONI, N
    RUSSO, D
    GUERRASIO, A
    SAGLIO, G
    TURA, S
    HAEMATOLOGICA, 1992, 77 (01) : 16 - 20
  • [40] IMMUNOLOGICAL CHARACTERIZATION OF THE TUMOR-SPECIFIC BCR ABL JUNCTION OF PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOID-LEUKEMIA
    BARRETT, J
    GUIMARAES, A
    CULLIS, J
    GOLDMAN, JM
    STEM CELLS, 1993, 11 : 104 - 108
12345